InsidersTradesSigma
Track the Bavarian Nordic A/S stock price and the full insider trade history of the company, a listed equity based in Denmark. Shares are listed on the DK market, under the oversight of Finanstilsynet DK. Operating in the Healthcare & Pharma sector, Bavarian Nordic A/S has logged 82 reports. Market capitalisation: €13.7bn. The latest transaction was disclosed on 13 May 2026 (Other). Every trade is accessible without an account.
82
Insider Decl.
n/a
Thresholds
€717,105
7 ops.
Buy Volume
€3m
4 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Bavarian Nordic A/S Strong Buy (bullish), based on 4 analysts. Average price target: DKK 267.50.
16Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 1,080 of 28,835 companies
80.6
score / 100
Value82
Quality80
FCF yld8.5%
Earn yld8.5%
EV/EBITDA6.4x
ROE12%
Gross mgn49%
Net mgn22%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 13 May 2026
Declarations82 total
771 shares@ DKK 188.300.0001% mcap0.2% of flowShareOutside a trading venueISIN DK0015998017DK:1442171
10,642 shares@ DKK 177.650.0018% mcap2.1% of flowShareOutside a trading venueISIN DK0015998017DK:1426172
983 shares@ DKK 152.580.0001% mcap0.2% of flowShareOutside a trading venueISIN DK0015998017DK:1362382
12,543 shares@ DKK 108.710.0013% mcap1.6% of flowShareOutside a trading venueISIN DK0015998017DK:1347025
54,669 shares0ShareOutside a trading venueISIN DK0015998017DK:1333439
2,596 shares@ DKK 146.600.0004% mcap0.4% of flowShareNasdaq Copenhagen A/S, XCSEISIN DK0015998017DK:1330866
98,855 shares@ DKK 243.80270.022% mcap27.4% of flowShareNasdaq Copenhagen A/S, XCSEISIN DK0015998017DK:1315150
98,855 shares@ DKK 146.600.013% mcap16.5% of flowShareNasdaq Copenhagen A/S, XCSEISIN DK0015998017DK:1314963
200 shares@ DKK 275.970.0001% mcap0.1% of flowShareNasdaq Copenhagen A/S, XCSEISIN DK0015998017DK:1312612
2,966 shares0ShareOutside a trading venueISIN DK0015998017DK:1294225
823 shares@ DKK 273.250.0002% mcap0.3% of flowShareOutside a trading venueISIN DK0015998017DK:1289504
8,258 shares@ DKK 148.170.0011% mcap1.4% of flowShareOutside a trading venueISIN DK0015998017DK:1280657
26,736 shares@ DKK 108.880.0027% mcap3.3% of flowShareOutside a trading venueISIN DK0015998017DK:1279419
57,836 shares0ShareOutside a trading venueISIN DK0015998017DK:1264735
67,788 shares@ DKK 142.000.0090% mcap11.0% of flowShareNasdaq Copenhagen A/S, XCSEISIN DK0015998017DK:1262459
4,800 shares@ DKK 154.690.0007% mcap0.8% of flowShareNasdaq Copenhagen A/S, XCSEISIN DK0015998017DK:1246283
3,375 shares@ DKK 149.560.0005% mcap0.6% of flowShareNasdaq Copenhagen A/S, XCSEISIN DK0015998017DK:1246015
1,185 shares@ DKK 189.740.0002% mcap0.3% of flowShareOutside a trading venueISIN DK0015998017DK:1233231
9,000 shares@ DKK 155.800.0013% mcap1.6% of flowShareNasdaq Copenhagen A/S, XCSEISIN DK0015998017DK:1229638
12,976 shares@ DKK 99.530.0012% mcap1.5% of flowShareOutside a trading venueISIN DK0015998017DK:1224301
2,313 shares0ShareOutside a trading venueISIN DK0015998017DK:1222422
14,000 shares@ DKK 155.800.0020% mcap2.5% of flowShareNasdaq Copenhagen A/S, XCSEISIN DK0015998017DK:1213965
10,642 shares@ DKK 151.550.0015% mcap1.8% of flowShareOutside a trading venueISIN DK0015998017DK:1210681
5,845 shares@ DKK 126.550.0007% mcap0.8% of flowShareOutside a trading venueISIN DK0015998017DK:1207954
88,325 shares0ShareOutside a trading venueISIN DK0015998017DK:1196330
25 of 82 declarations
About Bavarian Nordic A/S
Bavarian Nordic A/S is a Danish biopharmaceutical company focused on the development of vaccines and treatments for infectious diseases and cancer. It emphasizes innovation in therapeutic and preventive vaccines.
